# A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems

> **NCT03723785** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 58 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin icodec

## Key facts

- **NCT ID:** NCT03723785
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-09
- **Primary completion:** 2019-09-06
- **Final completion:** 2019-09-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723785, "A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03723785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*